Treatment and Survival Outcomes for Indigenous and Non‐Indigenous Australians Within the Victorian Lung Cancer Registry: A Retrospective Cross‐Sectional Cohort Study
Medical Journal of Australia · 2026-07 · 224 (7)
DOI: 10.5694/mja2.70232 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Medical Journal of Australia, online erschienen am 28.06.2026. Verfasst von Melanie Wong und 33 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Alfred Health, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Lung Neoplasms. Die Arbeit nennt 41 Literaturangaben.
Abstract (Originalsprache)
Objectives
Our goal was to explore and compare risk factors, patterns of management and survival outcomes in Indigenous compared with non‐Indigenous Australian patients using the Victorian Lung Cancer Registry (VLCR). Study Type A retrospective observational cohort study of the VLCR.
Setting
Data collected from the VLCR between 18 January 2011 and 24 January 2024.
Participants
Primary lung cancer patients in the VLCR. Main Outcome Measures Patient, disease and management characteristics of Indigenous and non‐Indigenous Australian patients. Impacts of patient and clinical variables on treatment and survival, measured by multivariable Cox regression and propensity‐matched survival analysis.
Results
We included 186 Indigenous and 17,439 non‐Indigenous Australian patients. Indigenous Australian lung cancer patients were younger in age {median, 62 years (interquartile range [IQR], 55–69 years) vs. median, 71 years (IQR, 63–77 years); p < 0.001}, had lower socio‐economic status (lowest quintile, 57 patients [31%] vs. 3274 patients [19%]; p < 0.001), were more likely to be current smokers (118 patients [65%] vs. 5963 patients [35%]; p < 0.001) and had higher levels of respiratory comorbidity (64 patients [34%] vs. 4088 patients [23%]; p < 0.001). There were no statistically significant differences in receipt of guideline‐concordant treatment (82 patients [51%] vs. 8036 patients [56%]; p = 0.12) and survival outcomes (median survival, 1.4 vs. 1.5 years; hazard ratio, 1.06 [95% confidence interval, 0.88–1.27]).
Conclusion
We found lung cancer patients of Indigenous status were more likely to have demographic disadvantage and clinical risk factors that may contribute to discrepancies in management compared with patients of non‐Indigenous status. Identifying barriers to healthcare and treatment in the Indigenous Australian population is an important research priority to improve disparities between the two populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory Medicine, Alfred Health, Melbourne, Victoria, Australia.
- Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
- School of Public Health and Preventive Medicine, Monash University, The Alfred Centre, Melbourne, Victoria, Australia.
- The Poche SA & NT Centre, Flinders University, Adelaide, South Australia, Australia.
- The Kids Research Institute Australia, Nedlands, Western Australia, Australia.
- Victorian Aboriginal Community Controlled Health Organisation, Melbourne, Victoria, Australia.
ORCID-Profile: Melanie Wong, Zoe K McQuilten, Rob Stirling
Zitieren
APA
Wong, M., Lloyd, M., Zeng, J., Tissera, S., Griffiths, K. E., Clark, J., Gillies, J., Briggs, L., Lesage, J., Wood, T., Underhill, C., Parakh, S., Irving, L. B., Faisal, W., Blum, R., Richardson, G. E., Parente, P., Caldecott, M., Olesen, I., …, & Stirling, R. (2026). Treatment and Survival Outcomes for Indigenous and Non‐Indigenous Australians Within the Victorian Lung Cancer Registry: A Retrospective Cross‐Sectional Cohort Study. Medical Journal of Australia, 224(7). https://doi.org/10.5694/mja2.70232
Vancouver
Wong M, Lloyd M, Zeng J, Tissera S, Griffiths KE, Clark J, et al. Treatment and Survival Outcomes for Indigenous and Non‐Indigenous Australians Within the Victorian Lung Cancer Registry: A Retrospective Cross‐Sectional Cohort Study. Medical Journal of Australia. 2026;224(7). doi:10.5694/mja2.70232
BibTeX
@article{Wong2026,
author = {Wong, Melanie and Lloyd, Mike and Zeng, Jessie and Tissera, Sanuki and Griffiths, Kalinda E and Clark, Justine and Gillies, Jonathan and Briggs, Lisa and Lesage, Jacqueline and Wood, Tom and Underhill, Craig and Parakh, Sagun and Irving, Louis B and Faisal, Wasek and Blum, Rob and Richardson, Gary E and Parente, Phillip and Caldecott, Michelle and Olesen, Inger and Torres, Javier and Samuel, Evangeline and Lyne, Christopher and See, Katharine and Langton, David and John, Thomas and Wright, Gavin and Conron, Matthew and Bartlett, James and Adabi, Golsa and Moore, Maggie and Harden, Susan and McQuilten, Zoe K and Zalcberg, John R and Stirling, Rob},
title = {Treatment and Survival Outcomes for Indigenous and Non‐Indigenous Australians Within the Victorian Lung Cancer Registry: A Retrospective Cross‐Sectional Cohort Study},
journal = {Medical Journal of Australia},
year = {2026},
volume = {224},
number = {7},
doi = {10.5694/mja2.70232}
}
EUVIMED